134 related articles for article (PubMed ID: 10830861)
21. V(IV)O and Cu(II) complexation by ligands based on pyridine nitrogen donors.
Sanna D; Buglyó P; Tomaz AI; Costa Pessoa J; Borović S; Micera G; Garribba E
Dalton Trans; 2012 Nov; 41(41):12824-38. PubMed ID: 22975792
[TBL] [Abstract][Full Text] [Related]
22. New oxovanadium bis(1,2-dithiolate) compounds that mimic the hydrogen-bonding interactions at the active sites of mononuclear molybdenum enzymes.
Cooney JJ; Carducci MD; McElhaney AE; Selby HD; Enemark JH
Inorg Chem; 2002 Dec; 41(26):7086-93. PubMed ID: 12495349
[TBL] [Abstract][Full Text] [Related]
23. Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity.
Sasmal PK; Saha S; Majumdar R; Dighe RR; Chakravarty AR
Inorg Chem; 2010 Feb; 49(3):849-59. PubMed ID: 20039725
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer.
D'Cruz OJ; Dong Y; Uckun FM
Anticancer Drugs; 2000 Nov; 11(10):849-58. PubMed ID: 11142693
[TBL] [Abstract][Full Text] [Related]
25. Oxovanadium(IV) complexes with aromatic aldehydes.
Pessoa JC; Cavaco I; Correia I; Tomaz I; Duarte T; Matias PM
J Inorg Biochem; 2000 May; 80(1-2):35-9. PubMed ID: 10885461
[TBL] [Abstract][Full Text] [Related]
26. Axial ligand coordination in sterically strained vanadyl porphyrins: synthesis, structure, and properties.
Ghosh SK; Patra R; Rath SP
Inorg Chem; 2008 Nov; 47(21):9848-56. PubMed ID: 18823111
[TBL] [Abstract][Full Text] [Related]
27. Oxidation of p-chlorotoluene and cyclohexene catalysed by polymer-anchored oxovanadium(IV) and copper(II) complexes of amino acid derived tridentate ligands.
Maurya MR; Kumar M; Kumar A; Costa Pessoa J
Dalton Trans; 2008 Aug; (32):4220-32. PubMed ID: 18682861
[TBL] [Abstract][Full Text] [Related]
28. Structural study of the interaction of vanadate with the ligand 1,2-dimethyl-3-hydroxy-4-pyridinone (Hdmpp) in aqueous solution.
Castro MM; Geraldes CF; Gameiro P; Pereira E; Castro B; Rangel M
J Inorg Biochem; 2000 May; 80(1-2):177-9. PubMed ID: 10885483
[TBL] [Abstract][Full Text] [Related]
29. Spectroscopic and theoretical study on the interaction between diperoxovanadate complexes and glycyl-histidine.
Zhang J; Yu X; Zeng B; Cai S; Chen Z
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Nov; 77(4):825-31. PubMed ID: 20822949
[TBL] [Abstract][Full Text] [Related]
30. Vanadium(V) compounds with the bis-(hydroxylamino)-1,3,5-triazine ligand, H2bihyat: synthetic, structural, and physical studies of [V2(V)O3(bihyat)2] and of the enhanced hydrolytic stability species cis-[V(V)O2(bihyat)]-.
Nikolakis VA; Tsalavoutis JT; Stylianou M; Evgeniou E; Jakusch T; Melman A; Sigalas MP; Kiss T; Keramidas AD; Kabanos TA
Inorg Chem; 2008 Dec; 47(24):11698-710. PubMed ID: 19006295
[TBL] [Abstract][Full Text] [Related]
31. Insulin mimesis of vanadium derivatives. Oxidation of cysteine by V(V) oxo diperoxo complexes.
Ballistreri FP; Barbuzzi EG; Tomaselli GA; Toscano RM
J Inorg Biochem; 2000 May; 80(1-2):173-6. PubMed ID: 10885482
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state.
Morgenstern B; Kutzky B; Neis C; Stucky S; Hegetschweiler K; Garribba E; Micera G
Inorg Chem; 2007 May; 46(10):3903-15. PubMed ID: 17419616
[TBL] [Abstract][Full Text] [Related]
33. Model Investigations for Vanadium-Protein Interactions. Synthetic, Structural, and Physical Studies of Vanadium(III) and Oxovanadium(IV/V) Complexes with Amidate Ligands.
Keramidas AD; Papaioannou AB; Vlahos A; Kabanos TA; Bonas G; Makriyannis A; Rapropoulou CP; Terzis A
Inorg Chem; 1996 Jan; 35(2):357-367. PubMed ID: 11666216
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of oxovanadium(IV) complexes of Schiff-base condensates from 5-substituted-2-hydroxybenzaldehyde and 2-substituted-benzenamine as selective inhibitors of protein tyrosine phosphatase 1B.
Han H; Lu L; Wang Q; Zhu M; Yuan C; Xing S; Fu X
Dalton Trans; 2012 Aug; 41(36):11116-24. PubMed ID: 22864521
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(IV), oxovanadium(V) and mu-bis(oxo)bis{oxovanadium(V)} complexes.
Maurya MR; Agarwal S; Abid M; Azam A; Bader C; Ebel M; Rehder D
Dalton Trans; 2006 Feb; (7):937-47. PubMed ID: 16462954
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, spectroscopic characterization and reactivity studies of oxovanadium(IV) complexes with bulky N,N'-polymethylenebis(3,5-(t)Bu(2)salicylaldimine) ligands.
Kasumov VT; Köksal F; Aslanoglu M; Yerli Y
Spectrochim Acta A Mol Biomol Spectrosc; 2010 Oct; 77(3):630-7. PubMed ID: 20674475
[TBL] [Abstract][Full Text] [Related]
37. Peroxo heteroligand vanadates(V): synthesis, spectra-structure relationships, and stability toward decomposition.
Djordjevic C; Vuletic N; Renslo ML; Puryear BC; Alimard R
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):25-9. PubMed ID: 8927044
[TBL] [Abstract][Full Text] [Related]
38. Oxidovanadium(IV) Schiff base complex derived from vitamin B6: synthesis, characterization, and insulin enhancing properties.
Mukherjee T; Costa Pessoa J; Kumar A; Sarkar AR
Inorg Chem; 2011 May; 50(10):4349-61. PubMed ID: 21495653
[TBL] [Abstract][Full Text] [Related]
39. Oxovanadium(IV) complexes of phenanthroline bases: the dipyridophenazine complex as a near-IR photocytotoxic agent.
Sasmal PK; Saha S; Majumdar R; De S; Dighe RR; Chakravarty AR
Dalton Trans; 2010 Feb; 39(8):2147-58. PubMed ID: 20148235
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the binding of oxovanadium(IV) to human serum albumin.
Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T
Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
